Zura Bio (ZURA) Common Equity (2021 - 2026)
Zura Bio's Common Equity came in at $177.66 million for Q3 2026, up 61.8% from $109.78 million a year earlier but down 9.9% from the prior quarter.
Powered by 
Analysis
Zura Bio (ZURA) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, Zura Bio's Common Equity was $101.54 million, down 31.6% from FY2024.
- Going back by year, Common Equity was $148.36 million in FY2024 (+143.7%), $60.87 million in FY2023, -$32.06 million in FY2022 and -$9.18 million in FY2021.
- The five-year range for quarterly Common Equity is -$32.06 million (Q4 2022) to $216.9 million (Q1 2026).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 44.9% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q4 2024 (growth of 143.7%), and the weakest in Q4 2025 (a decline of 31.6%).
- Business Quant data shows ZURA's Common Equity at $197.09 million (Q2 2026), $216.9 million (Q1 2026) and $101.54 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Zura Bio | 178.80 Mn | -549.04 Mn | - | 177.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 177.66 Mn |
| Jun 30, 2026 | 197.09 Mn |
| Mar 31, 2026 | 216.90 Mn |
| Dec 31, 2025 | 101.54 Mn |
| Sep 30, 2025 | 109.78 Mn |
| Jun 30, 2025 | 127.45 Mn |
| Mar 31, 2025 | 139.74 Mn |
| Dec 31, 2024 | 148.36 Mn |
| Sep 30, 2024 | 154.29 Mn |
| Jun 30, 2024 | 158.06 Mn |
| Mar 31, 2024 | 62.55 Mn |
| Dec 31, 2023 | 60.87 Mn |
| Sep 30, 2023 | 64.76 Mn |
| Jun 30, 2023 | 70.45 Mn |
| Mar 31, 2023 | 27.86 Mn |
| Dec 31, 2022 | -32.06 Mn |
| Sep 30, 2022 | -9.53 Mn |
| Jun 30, 2022 | -8.44 Mn |
| Mar 31, 2022 | -7.82 Mn |
| Dec 31, 2021 | -9.18 Mn |
API Access
Zura Bio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ZURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ZURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ZURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();